Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03500731 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 2025 to Dec 2027
    • Study completion date: Dec 2026 to Dec 2028
    • Site contacts updated at 1 of 2 sites
    v12
  2. Primary completion date: Dec 2024 to Dec 2025
    • Site contacts updated at 1 of 2 sites
    v11
  3. Primary completion date: Dec 2023 to Dec 2024v10
  4. Re-verified, no change to tracked fieldsv9
  5. Eligibility criteria expanded, about 64 wordsv8
Show 6 earlier versionsHide 6 earlier versions
  1. 2 versions Re-verified since Mar 20, 2020, no change to tracked fieldsv6-v7
  2. Site contacts updated at 1 of 2 sitesv5
  3. Study sites: 1 to 2v4
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2018 to Apr 19, 2018
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine whether a lung transplantation prior to bone marrow transplantation (BMT) would allow for restoration of pulmonary function prior to BMT, allowing to proceed to BMT, to restore hematologic function.
Trial Details
NCT Number NCT03500731
Lead Sponsor Paul Szabolcs
Conditions
(from sponsor)		 Idiopathic Pulmonary Fibrosis, Emphysema or COPD
Related terms Emphysema, Idiopathic Pulmonary Fibrosis, Pulmonary Disease, Chronic Obstructive, Pulmonary Fibrosis
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov